Gerresheimer AG (ETR:GXI – Get Free Report) shares shot up 0.9% during trading on Wednesday . The company traded as high as €69.45 ($70.87) and last traded at €69.45 ($70.87). 202,264 shares were traded during trading, an increase of 44% from the average session volume of 140,925 shares. The stock had previously closed at €68.85 ($70.26).
Gerresheimer Stock Down 0.2 %
The company has a quick ratio of 0.40, a current ratio of 0.87 and a debt-to-equity ratio of 79.36. The business has a fifty day simple moving average of €73.89 and a two-hundred day simple moving average of €87.71. The company has a market capitalization of $2.38 billion, a price-to-earnings ratio of 20.72, a P/E/G ratio of 0.82 and a beta of 0.94.
About Gerresheimer
Gerresheimer AG, together with its subsidiaries, manufactures and sells medicine packaging, drug delivery devices, and solutions in Germany and internationally. It operates through three divisions: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. The company offers prefillable syringes, plastic and glass packaging solutions, vials, glass cartridges and ampoules, bottles and containers, and glass bottles and jars, as well as caps, closures, applicators, and accessories; development, industrialization and contract manufacturing of drug delivery programs; project and quality management; and drug delivery systems, including inhalers, injection/auto injectors, pen injectors, infusion systems, and inhalation assessment, autoinjector, and other services.
Recommended Stories
- Five stocks we like better than Gerresheimer
- What is the S&P 500 and How It is Distinct from Other Indexes
- Driving Forward: Lucid’s Growing Sales and Gravity SUV’s Impact
- What is an Earnings Surprise?
- Why Amazon’s Next Earnings Could Trigger a Stock Breakout
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- With This Kind of Data, The Fed Isn’t Cutting Rates This Year
Receive News & Ratings for Gerresheimer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer and related companies with MarketBeat.com's FREE daily email newsletter.